These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 2642286)
1. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin. Koga M; Musgrove EA; Sutherland RL Cancer Res; 1989 Jan; 49(1):112-6. PubMed ID: 2642286 [TBL] [Abstract][Full Text] [Related]
2. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Murphy LJ; Sutherland RL; Stead B; Murphy LC; Lazarus L Cancer Res; 1986 Feb; 46(2):728-34. PubMed ID: 3000583 [TBL] [Abstract][Full Text] [Related]
3. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells. Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830 [TBL] [Abstract][Full Text] [Related]
4. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies. Horwitz KB; Freidenberg GR Cancer Res; 1985 Jan; 45(1):167-73. PubMed ID: 3838085 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells. Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041 [TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T 47D human breast cancer cell growth. Koga M; Sutherland RL Biochem Biophys Res Commun; 1987 Jul; 146(2):739-45. PubMed ID: 3497634 [TBL] [Abstract][Full Text] [Related]
7. Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor. Sarup JC; Rao KV; Fox CF Cancer Res; 1988 Sep; 48(18):5071-8. PubMed ID: 3044580 [TBL] [Abstract][Full Text] [Related]
8. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Koga M; Eisman JA; Sutherland RL Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048 [TBL] [Abstract][Full Text] [Related]
9. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines. Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines. Koga M; Musgrove EA; Sutherland RL Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells. Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. Murphy LC; Murphy LJ; Dubik D; Bell GI; Shiu RP Cancer Res; 1988 Aug; 48(16):4555-60. PubMed ID: 3260816 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins. Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051 [TBL] [Abstract][Full Text] [Related]
14. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400 [TBL] [Abstract][Full Text] [Related]
16. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768 [TBL] [Abstract][Full Text] [Related]
17. Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens. Murphy LC; Dotzlaw H Cancer Res; 1989 Feb; 49(3):599-604. PubMed ID: 2783382 [TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor: receptor and ligand expression in human breast cancer. Murphy LC; Dotzlaw H; Wong MS; Miller T; Mrockowski B; Gong Y; Murphy LJ Semin Cancer Biol; 1990 Oct; 1(5):305-15. PubMed ID: 2103505 [TBL] [Abstract][Full Text] [Related]
19. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. van der Burg B; Rutteman GR; Blankenstein MA; de Laat SW; van Zoelen EJ J Cell Physiol; 1988 Jan; 134(1):101-8. PubMed ID: 3275677 [TBL] [Abstract][Full Text] [Related]
20. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells. Seeger H; Wallwiener D; Mueck AO Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]